Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31494410 | 0.77 | RAB9A (0.52) | ALOX15KMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL29807808 | 0.76 | TSHR (0.61) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL29808205 | 0.76 | ALOX15 (0.42) | ALOX15KMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL29807963 | 0.74 | ALOX15 (0.40) | ALOX15KMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL29808248 | 0.74 | NPC1 (0.46) | ALOX15KMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL29808310 | 0.74 | ALOX15 (0.40) | ALOX15KMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL31494372 | 0.70 | SMN1; SMN2 (0.49) | KMT2ASMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL21889211 | 0.68 | SMN1; SMN2 (0.34) | SMN1; SMN2NPC1RAB9AALDH1A1HTT | |
| SCHEMBL21338139 | 0.67 | LMNA (0.53) | ALOX15KMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL5695138 | 0.67 | HSD17B10 (0.65) | ALOX15KMT2ASMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220274968-A1 | Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 | GBIOTECH S.À.R.L. (CH) | 2022-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220274968-A1 | Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 | FFAR2, FFAR1, FFAR3 | ALOX15 111/4885KMT2A 3784/4885SMN1; SMN2 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.